ICRF-159 (razoxane) in patients with advanced squamous cell carcinoma of the uterine cervix. For the Gynecologic Oncology Group.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/49B2CF0A.svg?ark=w1%2F20260515%2F49B2CF0A)](https://nobleid.org/work/w1/20260515/49B2CF0A)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors